Jinthe Van Loenhout

986 total citations
16 papers, 803 citations indexed

About

Jinthe Van Loenhout is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jinthe Van Loenhout has authored 16 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Jinthe Van Loenhout's work include Nanoplatforms for cancer theranostics (5 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Immunotherapy and Immune Responses (4 papers). Jinthe Van Loenhout is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Immunotherapy and Immune Responses (4 papers). Jinthe Van Loenhout collaborates with scholars based in Belgium, Australia and Germany. Jinthe Van Loenhout's co-authors include Evelien Smits, Annemie Bogaerts, Christophe Deben, Marc Peeters, Abraham Lin, Joey De Backer, Wilma Van Boxem, Jorrit De Waele, Sylvia Dewilde and Filip Lardon and has published in prestigious journals such as International Journal of Molecular Sciences, Advanced Science and Oncotarget.

In The Last Decade

Jinthe Van Loenhout

16 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinthe Van Loenhout Belgium 11 296 267 205 177 173 16 803
Zheng Han China 16 151 0.5× 376 1.4× 206 1.0× 84 0.5× 153 0.9× 50 947
Vessela Vassileva United Kingdom 14 199 0.7× 404 1.5× 466 2.3× 169 1.0× 120 0.7× 21 1.1k
Venkatesh Chelvam India 21 133 0.4× 339 1.3× 121 0.6× 61 0.3× 185 1.1× 52 1.2k
Haiqing Zhong China 16 76 0.3× 161 0.6× 192 0.9× 160 0.9× 81 0.5× 33 658
Sarah Tam United States 21 314 1.1× 314 1.2× 240 1.2× 249 1.4× 753 4.4× 36 1.5k
Sílvia Barrabés Spain 14 143 0.5× 640 2.4× 178 0.9× 192 1.1× 66 0.4× 21 842
Yawen Guo China 18 45 0.2× 326 1.2× 179 0.9× 122 0.7× 142 0.8× 51 1.0k
Jungshan Chang Taiwan 19 56 0.2× 386 1.4× 223 1.1× 156 0.9× 200 1.2× 50 909
Stephan Rogalla United States 15 76 0.3× 265 1.0× 110 0.5× 141 0.8× 302 1.7× 31 789

Countries citing papers authored by Jinthe Van Loenhout

Since Specialization
Citations

This map shows the geographic impact of Jinthe Van Loenhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinthe Van Loenhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinthe Van Loenhout more than expected).

Fields of papers citing papers by Jinthe Van Loenhout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinthe Van Loenhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinthe Van Loenhout. The network helps show where Jinthe Van Loenhout may publish in the future.

Co-authorship network of co-authors of Jinthe Van Loenhout

This figure shows the co-authorship network connecting the top 25 collaborators of Jinthe Van Loenhout. A scholar is included among the top collaborators of Jinthe Van Loenhout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinthe Van Loenhout. Jinthe Van Loenhout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Boullosa, Laurie Freire, Jinthe Van Loenhout, Tal Flieswasser, et al.. (2023). Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants. 12(3). 667–667. 16 indexed citations
2.
Boullosa, Laurie Freire, Jinthe Van Loenhout, Christophe Hermans, et al.. (2022). Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics. 14(12). 2761–2761. 7 indexed citations
3.
4.
Boullosa, Laurie Freire, Jinthe Van Loenhout, Tal Flieswasser, et al.. (2021). Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer. Redox Biology. 42. 101949–101949. 85 indexed citations
5.
Loenhout, Jinthe Van, Laurie Freire Boullosa, Delphine Quatannens, et al.. (2021). Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma. Cells. 10(11). 2936–2936. 56 indexed citations
6.
Audenaerde, Jonas R.M. Van, Elly Marcq, Bianca von Scheidt, et al.. (2020). Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment. Clinical & Translational Immunology. 9(8). e1165–e1165. 28 indexed citations
7.
Loenhout, Jinthe Van, Marc Peeters, Annemie Bogaerts, Evelien Smits, & Christophe Deben. (2020). Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects. Antioxidants. 9(12). 1188–1188. 77 indexed citations
8.
Flieswasser, Tal, Jinthe Van Loenhout, Laurie Freire Boullosa, et al.. (2020). Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer. Cells. 9(6). 1474–1474. 41 indexed citations
9.
Lin, Abraham, Wilma Van Boxem, Jinthe Van Loenhout, et al.. (2019). The Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment. Cancers. 11(9). 1287–1287. 89 indexed citations
10.
Lin, Abraham, Yury Gorbanev, Joey De Backer, et al.. (2019). Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells. Advanced Science. 6(6). 1802062–1802062. 203 indexed citations
11.
Marcq, Elly, Jonas R.M. Van Audenaerde, Jorrit De Waele, et al.. (2019). Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression. International Journal of Molecular Sciences. 20(17). 4182–4182. 10 indexed citations
12.
Loenhout, Jinthe Van, Tal Flieswasser, Laurie Freire Boullosa, et al.. (2019). Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells. Cancers. 11(10). 1597–1597. 89 indexed citations
13.
Loenhout, Jinthe Van, Christophe Deben, Julie Jacobs, et al.. (2018). Immunogenic Potential Of Cold Atmospheric Plasma For The Treatment Of Pancreatic Cancer. VUBIR (Vrije Universiteit Brussel). 9. 26–26. 3 indexed citations
14.
Waele, Jorrit De, Elly Marcq, Jonas R.M. Van Audenaerde, et al.. (2018). PO-419 Poly(I:C) prepares glioblastoma cells for anti-PD-L1 therapy via lymphocyte attraction and activation in a TLR3-dependent manner. ESMO Open. 3. A394–A395. 1 indexed citations
15.
Waele, Jorrit De, Elly Marcq, Jonas R.M. Van Audenaerde, et al.. (2017). Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade. OncoImmunology. 7(3). e1407899–e1407899. 36 indexed citations
16.
Audenaerde, Jonas R.M. Van, Jorrit De Waele, Elly Marcq, et al.. (2017). Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells. Oncotarget. 8(34). 56968–56979. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zheng Han Breakdown of academic impact, for papers by Vessela Vassileva Breakdown of academic impact, for papers by Venkatesh Chelvam Breakdown of academic impact, for papers by Haiqing Zhong Breakdown of academic impact, for papers by Sarah Tam Breakdown of academic impact, for papers by Sílvia Barrabés Breakdown of academic impact, for papers by Yawen Guo Breakdown of academic impact, for papers by Jungshan Chang Breakdown of academic impact, for papers by Stephan Rogalla
Rankless by CCL
2026